Close

Jefferies Lifts Target on Celgene (CELG) to $72; Still Positive on Revlimid Prospects Amid Flat Outlook Oct 28, 2011 08:59AM
Jefferies Lifts Price Target on Celgene (CELG) After Strong Q2 Jul 29, 2011 11:54AM
Jefferies Checks into Celgene (CELG), Suggests No Change to Rev Maintenance in IFM-DFCI Study Jun 21, 2011 08:53AM
Jefferies Comments on Celgene Corp. (CELG) Following Weekend Update From ASCO Jun 6, 2011 11:47AM
Jefferies Raises Price Target on Celgene (CELG) Following Q1 Results Apr 29, 2011 09:44AM


Jan 28, 2011 09:21AM Jefferies Lowers Price Target on Celgene (CELG), Maintains Buy Rating
Jun 7, 2010 11:01AM Notable Analyst Rating Changes 06/07: BMY, EGLE, CELG, NILE Upgraded; BP, TEL, SPWRA, ABT Downgraded
Jun 7, 2010 07:56AM Jefferies & Co Upgrades Celgene (CELG) to Buy
Apr 9, 2010 10:39AM Notable Analyst Rating Changes 04/09: JCP, BJ, DISH, WSM Upgraded; MGM, AA, ZLC, CELG Downgraded
Apr 9, 2010 07:48AM Jefferies & Co Downgrades Celgene (CELG) to Hold
Dec 18, 2009 09:32AM Jefferies & Co Initiates/Resumes Coverage on Pharma/Biotechnology Stocks
Sep 2, 2009 10:14AM Notable Analyst Rating Changes 9/2: TXT, CBE, SI, PAY, BBD Upgraded; ROK, GIS, HOLX, DHI, RYL, NVAX Downgraded
Jul 28, 2009 10:19AM Notable Analyst Rating Changes 7/28: X, AA, ENOC, IR, UFS Upgraded; DB, PM, WGOV, CRM Downgraded
Feb 18, 2009 10:04AM Notable Analyst Rating Changes 2/18: S, SNN, NYX, CPRT Upgraded; ENTG, HOS, GPC, AMX Downgraded
Jan 31, 2008 10:50AM David Moenning's Daily State of the Markets: 1/31